43 results
SD
TAK
Takeda Pharmaceutical Co
25 Apr 24
Conflict minerals disclosure
6:04am
with raw materials and ending with the finished product that a patient receives. As a result, Takeda elected to use a “product-centric” approach
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
6 Jul 23
Current report (foreign)
6:18am
or Recycling Raw Materials R&D and Manufacturing End-of-Life Distribution “ We want to deliver products to patients that transform their lives, while minimizing
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
23 Jun 23
Current report (foreign)
6:13am
388,195 415,346 Raw materials and supplies 39,399 32,087 Current portion of bonds 106,715 101,960 Income taxes receivables 2,192 - Current portion of long
6-K
EX-99.1
0hn4j37h 7jiv1
30 May 23
Current report (foreign)
6:14am
6-K
EX-99.1
r0xhvm2s gnj
30 May 23
Current report (foreign)
6:11am
SD
vsr dz3b27v
15 May 23
Conflict minerals disclosure
6:09am
6-K
EX-99.1
ilu1dg9krghg5
31 May 22
Current report (foreign)
6:07am
6-K
EX-99.1
1sn5vj79
31 May 22
Current report (foreign)
12:00am
SD
2hnq9855pp5b
13 May 22
Conflict minerals disclosure
6:10am
6-K
t646km3ir3v o2223tb
11 May 22
Current report (foreign)
6:06am
6-K
EX-99.1
8yptgd4yxjjt 3bekt3f
29 Jun 21
Current report (foreign)
7:38am
6-K
EX-99.1
ssjx9
28 May 21
Current report (foreign)
6:03am
6-K
EX-99.1
k56noi4v
28 May 21
Current report (foreign)
6:01am
SD
959vyxtdxpqf5soov7te
17 May 21
Conflict minerals disclosure
6:21am
6-K
cbmj2q46mgy5nji
11 May 21
Current report (foreign)
6:08am